Insider Selling: Phreesia, Inc. (NYSE:PHR) Insider Sells $17,298.00 in Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 744 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $17,298.00. Following the transaction, the insider now directly owns 30,019 shares in the company, valued at approximately $697,941.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Yvonne Hui also recently made the following trade(s):

• On Tuesday, July 16th, Yvonne Hui sold 283 shares of Phreesia stock. The shares were sold at an average price of $23.74, for a total value of $6,718.42.

Phreesia Price Performance

Shares of PHR opened at $24.69 on Friday. The firm has a market capitalization of $1.42 billion, a PE ratio of -11.38 and a beta of 0.93. The stock’s 50 day moving average is $23.72 and its two-hundred day moving average is $22.73. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $29.16. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03.

Institutional Trading of Phreesia

A number of institutional investors have recently modified their holdings of PHR. Capital International Investors lifted its holdings in Phreesia by 221.1% in the first quarter. Capital International Investors now owns 2,593,063 shares of the company’s stock valued at $62,052,000 after acquiring an additional 1,785,463 shares during the period. Champlain Investment Partners LLC acquired a new stake in shares of Phreesia in the first quarter valued at about $29,941,000. Brown Advisory Inc. boosted its holdings in Phreesia by 22.2% during the fourth quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock worth $91,451,000 after buying an additional 716,374 shares in the last quarter. Norges Bank acquired a new position in Phreesia during the fourth quarter worth about $8,199,000. Finally, Blair William & Co. IL increased its holdings in Phreesia by 42.6% in the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock valued at $18,012,000 after buying an additional 224,950 shares in the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have commented on PHR. Canaccord Genuity Group reaffirmed a “buy” rating and set a $34.00 price target on shares of Phreesia in a research report on Thursday, September 5th. Stephens reiterated an “overweight” rating and issued a $28.00 price target on shares of Phreesia in a research report on Friday, May 31st. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a report on Thursday, September 5th. Finally, JPMorgan Chase & Co. raised their price target on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, September 9th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $29.42.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.